Description: This product is colorless transparent liquid. Its main ingredients for two ammonium glycyrrhetate, its chemical name is: 20 beta-carboxyl-11-oxygen generation are neat block fruit alkanes-12- ene-3 beta base-2-O-beta -D - grapes pyranoside hyaluronic acid base -ɑ-D-grapes pyranoside hyaluronic acid ammonium salt. It apply to ALT increased with chronic persistent hepatitis and chronic active hepatitis.
pharmacological effects: Diammonium Glycyrrhizinate for Injection has strong anti-inflammatory, and the liver cells and improve liver function. Pharmacological experiments prove that mice orally to relieve carbon tetrachloride, Thioacetamide and D-galactosamine-induced serum alanine aminotransferase and aspartate aminotransferase increased. Also reduced significantly D-galactose right of liver damage and improve immune factor on the form of chronic liver injury.
Pharmacokinetics: after intravenous injection of about 92% of the drug and plasma protein binding, the average residence time of 8 hours; In vivo lung, liver and kidney distribution of the maximum, other organizations, spleen, heart , stomach, small intestine, testis, brain distribution of low, mainly through intravenous from fecal bile from, some from respiratory to emit CO2, from the small amount of urine.
indications: apply to ALT increased with chronic persistent hepatitis and chronic active hepatitis.
adverse reaction: basically no obvious adverse reactions. A small number of patients have high blood pressure, dizziness, headache, nausea, abdominal discomfort, bloating, skin rash and fever, but does not affect the treatment.
